Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurotoxicity Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT01953159
What this trial is testing

Assessment of Paclitaxel-Induced Neuropathy

Who this might be right for
CancerBreast CancerOvarian Cancer
University of Chicago 43
Post-approval studies (Phase 4)Study completedNCT05094154
What this trial is testing

Effect of Antibiotic Choice On ReNal Outcomes (ACORN)

Who this might be right for
SepsisAKINeurotoxicity
Vanderbilt University Medical Center 2,634
Testing effectiveness (Phase 2)Looking for participantsNCT07106671
What this trial is testing

A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma

Who this might be right for
CRS - Cytokine Release SyndromeMyeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)Study completedNCT01442727
What this trial is testing

Selenium in the Treatment of Arsenic Toxicity and Cancers

Who this might be right for
Arsenical MelanosisArsenical KeratosisArsenical Cancers+4 more
Texas Tech University 819
Not applicableActive Not RecruitingNCT04364945
What this trial is testing

Association Between Anesthetic Drugs for General Anesthesia and Postoperative Intelligence/behavioral Assessment Results in Children

Who this might be right for
Anesthesia and Neurotoxicity
Seoul National University Hospital 400
Not applicableNot Yet RecruitingNCT07388160
What this trial is testing

Neuroinflammatory Biomarkers After General Anesthesia: A Comparison Study

Who this might be right for
AnesthesiaNeuroinflammationCognitive Disorders
University of Health Sciences Balikesir Hospital Eduation and Research 160
Post-approval studies (Phase 4)UnknownNCT02544919
What this trial is testing

Lipids and Neurological Complications in Liver Transplantation

Who this might be right for
Neurological Complications
Mansoura University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06551051
What this trial is testing

ADC-induced Neurotoxicity Treated With Duloxetine

Who this might be right for
Solid Tumour
Fudan University 37
Large-scale testing (Phase 3)Study completedNCT00039780
What this trial is testing

Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel

Who this might be right for
Breast NeoplasmsBreast DiseasesMetastases, Neoplasm
BioNumerik Pharmaceuticals, Inc. 764
Testing effectiveness (Phase 2)Ended earlyNCT01499940
What this trial is testing

Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway

Who this might be right for
Neurotoxicity
Gerald Higa, PharmD. 9
Not applicableStudy completedNCT03348956
What this trial is testing

Biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity

Who this might be right for
CIPN - Chemotherapy-Induced Peripheral Neuropathy
Dartmouth-Hitchcock Medical Center 7
Testing effectiveness (Phase 2)Study completedNCT04359784
What this trial is testing

Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy

Who this might be right for
B-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center 27
Not applicableLooking for participantsNCT07780955
What this trial is testing

Multimodal Assessment of Cryotherapy for Paclitaxel-Induced Neuropathy

Who this might be right for
CIPN - Chemotherapy-Induced Peripheral NeuropathyCIPNCIPN in Adjuvant Breast Cancer Patients+2 more
Azienda Sanitaria dell'Alto Adige 144
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Not applicableStudy completedNCT03342586
What this trial is testing

Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity

Who this might be right for
Central Nervous System Lymphoma
Memorial Sloan Kettering Cancer Center 14
Not applicableActive Not RecruitingNCT06798142
What this trial is testing

Risk Stratification and Heterogeneity for Organ Damage in Acute Diquat Poisoning

Who this might be right for
Toxic EncephalopathyDiquat Poisoning
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 193
Testing effectiveness (Phase 2)Ended earlyNCT00069927
What this trial is testing

Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

Who this might be right for
DepressionNeurotoxicityUnspecified Childhood Solid Tumor, Protocol Specific
University of South Florida 12
Not applicableStudy completedNCT03354455
What this trial is testing

Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 20
Not applicableUnknownNCT04335916
What this trial is testing

Survey on Pre-ECT Evaluation and ECT Application

Who this might be right for
DepressionCatatoniaSchizophrenia+3 more
Klinički Bolnički Centar Zagreb 30
Testing effectiveness (Phase 2)UnknownNCT00884767
What this trial is testing

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Who this might be right for
Chemotherapeutic Agent ToxicityColorectal CancerNeurotoxicity
Institut Cancerologie de l'Ouest 206
Next Page